pulmonaryfibrosisnews13d
MTX-463 expected to enter Phase 2 testing in IPF in first half of 2025
Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.
pulmonaryfibrosisnews2d
When we share our experiences with IPF, it’s not a competition
Everyone's IPF journey is unique, columnist Sam Kirton says, but that does not mean our experiences should become a competition.
pulmonaryfibrosisnews6d
Study uncovers why PF after severe COVID-19 doesn’t progress
An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...
pulmonaryfibrosisnews9d
Dealing with grief is unique to each of us in the PF community
Columnist Sam Kirton says that at his age, and as someone with pulmonary fibrosis, he's had much experience dealing with grief.
pulmonaryfibrosisnews24y
Strategies that make exercise with pulmonary fibrosis easier for me
Working out with pulmonary fibrosis can be challenging, but columnist Charlene Marshall has found some tips to make exercise easier.